Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

SELL
$9.83 - $9.96 $4.82 Million - $4.89 Million
-490,681 Reduced 82.63%
103,124 $1.02 Million
Q4 2022

Feb 08, 2023

SELL
$5.91 - $10.14 $2.12 Million - $3.64 Million
-358,927 Reduced 37.67%
593,805 $5.92 Million
Q3 2022

Nov 04, 2022

BUY
$3.65 - $6.74 $3.48 Million - $6.42 Million
952,732 New
952,732 $5.25 Million
Q2 2022

Jul 29, 2022

SELL
$3.65 - $6.04 $338,574 - $560,270
-92,760 Closed
0 $0
Q1 2022

May 05, 2022

SELL
$5.01 - $8.77 $160,224 - $280,473
-31,981 Reduced 25.64%
92,760 $559,000
Q4 2021

Jan 21, 2022

BUY
$7.64 - $10.11 $384,597 - $508,937
50,340 Added 67.66%
124,741 $1.05 Million
Q4 2019

Jan 29, 2020

SELL
$2.65 - $3.4 $496,856 - $637,476
-187,493 Reduced 71.59%
74,401 $212,000
Q3 2019

Nov 01, 2019

SELL
$2.52 - $3.79 $198,046 - $297,856
-78,590 Reduced 23.08%
261,894 $871,000
Q2 2019

Aug 09, 2019

SELL
$3.25 - $3.96 $41,099 - $50,078
-12,646 Reduced 3.58%
340,484 $1.11 Million
Q1 2019

May 13, 2019

SELL
$3.07 - $4.0 $36,545 - $47,616
-11,904 Reduced 3.26%
353,130 $1.32 Million
Q4 2018

Feb 11, 2019

SELL
$3.19 - $7.23 $144,188 - $326,796
-45,200 Reduced 11.02%
365,034 $1.26 Million
Q3 2018

Oct 26, 2018

SELL
$6.88 - $9.11 $35,555 - $47,080
-5,168 Reduced 1.24%
410,234 $2.94 Million
Q2 2018

Aug 08, 2018

BUY
$5.47 - $7.05 $460,787 - $593,884
84,239 Added 25.44%
415,402 $2.9 Million
Q1 2018

May 11, 2018

BUY
$5.6 - $6.94 $129,516 - $160,508
23,128 Added 7.51%
331,163 $2.04 Million
Q4 2017

Feb 06, 2018

BUY
$3.97 - $5.69 $130,470 - $186,996
32,864 Added 11.94%
308,035 $1.73 Million
Q3 2017

Nov 07, 2017

BUY
$3.77 - $6.04 $1.04 Million - $1.66 Million
275,171
275,171 $1.29 Million

Others Institutions Holding APEN

# of Institutions
1
Shares Held
527K
Call Options Held
0
Put Options Held
0

About Apollo Endosurgery, Inc.


  • Ticker APEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 40,686,500
  • Description
  • Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible en...
More about APEN
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.